Clinical Scorecard: Efficacy of Transcutaneous Electrical Acupoint Stimulation as a Preventive Measure Against Lymphedema in Breast Cancer Patients Undergoing Axillary Lymph Node Dissection

At a Glance

Key Highlights

• BCRL incidence after axillary lymph node dissection can be as high as 58.3%, with onset typically within 3 months to 3 years postoperatively.
• TEAS is a non-invasive, standardized, and reproducible therapy combining traditional acupuncture principles with modern electrical stimulation, avoiding risks of pain and infection.
• Current preventive measures for BCRL are limited; TEAS may offer an effective adjunct preventive therapy to improve patient quality of life.

Guideline-Based Recommendations

Diagnosis

• Monitor limb circumference, edema staging, and severity postoperatively.
• Use skin thickness ultrasound and lymphangiography to assess lymphatic function.
• Evaluate patient-reported swelling and lymphedema-related symptoms via VAS scores.

Management

• Administer TEAS starting one day before surgery through 3 days after surgery (excluding surgery day), then twice weekly for 4 weeks.
• Continue standard preventive measures including limb rehabilitation exercises and avoidance of limb trauma.
• Record and manage any adverse events during treatment.

Monitoring & Follow-up

• Follow patients monthly for 18 months postoperatively to assess incidence and onset time of lymphedema.
• Perform serial assessments of limb circumference, edema stage, ultrasound, lymphangiography, and inflammatory markers at defined intervals.
• Monitor patient symptoms and adverse events throughout the study period.

Risks

• Potential risks of TEAS are minimal due to its non-invasive nature; however, adverse events during the trial will be recorded and monitored.
• Avoid invasive procedures on the affected limb such as blood draws or blood pressure measurements to reduce lymphedema risk.

Patient & Prescribing Data

Breast cancer patients undergoing axillary lymph node dissection at risk for BCRL

TEAS administered perioperatively and postoperatively may reduce incidence and delay onset of lymphedema, improving patient outcomes and quality of life.

Clinical Best Practices

• Initiate TEAS treatment starting one day before surgery to maximize preventive effect.
• Combine TEAS with standard preventive care including limb exercises and protective measures.
• Use standardized protocols for TEAS application to ensure reproducibility and safety.
• Conduct long-term follow-up (up to 18 months) to monitor lymphedema development and treatment efficacy.
• Educate patients on limb care precautions to minimize lymphedema risk.

References

• Chinese Clinical Trial Registry - ChiCTR2400088117